We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Chromadex Corp
5 own
11 watching
Current Price
$0
$0.02
(0.92%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
133.61M
52-Week High
3.16
52-Week Low
1.15
Average Volume
0.18M
Dividend Yield
--
P/E Ratio
--
Market Capitalization133.61M52-Week High3.1652-Week Low1.15Average Volume0.18MDividend Yield--P/E Ratio--What does the Chromadex Corp do?
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and IMMULINA, a Braun-type lipoproteins, including spirulina extracts and active compounds, which are used to support human immune function. It also offers analytical reference standards and services comprising supply of products to conduct quality control of raw materials and consumer products in dietary supplements, cosmetics, food and beverages, life sciences, and pharmaceutical industries. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation is headquartered in Los Angeles, California.
Read More
How much money does Chromadex Corp make?
News & Events about Chromadex Corp.
Business Wire
1day ago
ChromaDex Corp. (NASDAQ:CDXC), a global bioscience company dedicated to healthy aging, announced promising findings from a first-of-its kind clinical study, as reported in the peer-reviewed journal Translational Neurodegeneration by a team of scientists led by Dr. Adil Mardinoglu, Professor of...
Business Wire
20days ago
ChromaDex Corp. (NASDAQ:CDXC), a global bioscience company dedicated to healthy aging, announced it has appointed Dr. Vilhelm (Will) Bohr, M.D., Ph.D., D.Sc. to its Scientific Advisory Board (SAB). Dr. Bohr is one of the worlds most published researchers on aging and neurodegenerative disease with...
Business Wire
27days ago
ChromaDex Corp. (NASDAQ:CDXC), a global bioscience company dedicated to healthy aging, announced that it has appointed Brianna Gerber to the role of Chief Financial Officer, effective January 1, 2023. Gerber served as Senior Vice President, Finance / Interim Chief Financial Officer of ChromaDex...
Business Wire
1month ago
ChromaDex Corp. (NASDAQ:CDXC), a global bioscience company dedicated to healthy aging, announced promising new findings based on a previously published clinical trial of companys proprietary Niagen ingredient (patented nicotinamide riboside or NR), which was supported by the ChromaDex External...
Business Wire
2 months ago
ChromaDex Corp. (NASDAQ:CDXC), a global bioscience company dedicated to healthy aging, today announced that on November 4, 2022, the U.S. FDA declared nicotinamide mononucleotide (NMN) may no longer be sold or marketed as a dietary supplement in the United States since it was first investigated as...
Frequently Asked Questions
Frequently Asked Questions
What is Chromadex Corp share price today?
Can Indians buy Chromadex Corp shares?
How can I buy Chromadex Corp shares from India?
Can Fractional shares of Chromadex Corp be purchased?
What are the documents required to start investing in Chromadex Corp stocks?
What is today’s traded volume of Chromadex Corp?
What is today’s market capitalisation of Chromadex Corp?
What is the 52-Week High and Low Range of Chromadex Corp?
What percentage is Chromadex Corp down from its 52-Week High?
What percentage is Chromadex Corp up from its 52-Week Low?
Current Price
$0
$0.02
(0.92%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.